User profiles for "author:Balázs Győrffy"

Balázs Győrffy

Clarivate Highly Cited, Semmelweis, PTE, HUN-REN, ELIXIR, Hungarian Academy of …
Verified email at ttk.mta.hu
Cited by 27954

[HTML][HTML] Validation of miRNA prognostic power in hepatocellular carcinoma using expression data of independent datasets

Á Nagy, A Lánczky, O Menyhárt, B Győrffy - Scientific reports, 2018 - nature.com
Multiple studies suggested using different miRNAs as biomarkers for prognosis of
hepatocellular carcinoma (HCC). We aimed to assemble a miRNA expression database …

[HTML][HTML] Multigene prognostic tests in breast cancer: past, present, future

B Győrffy, C Hatzis, T Sanft, E Hofstatter, B Aktas… - Breast cancer …, 2015 - Springer
There is growing consensus that multigene prognostic tests provide useful complementary
information to tumor size and grade in estrogen receptor (ER)-positive breast cancers. The …

[HTML][HTML] Multi-omics approaches in cancer research with applications in tumor subtyping, prognosis, and diagnosis

O Menyhárt, B Győrffy - Computational and structural biotechnology journal, 2021 - Elsevier
While cost-effective high-throughput technologies provide an increasing amount of data, the
analyses of single layers of data seldom provide causal relations. Multi-omics data …

[HTML][HTML] Web-based survival analysis tool tailored for medical research (KMplot): development and implementation

A Lánczky, B Győrffy - Journal of medical Internet research, 2021 - jmir.org
Background Survival analysis is a cornerstone of medical research, enabling the
assessment of clinical outcomes for disease progression and treatment efficiency. Despite …

[HTML][HTML] Online survival analysis software to assess the prognostic value of biomarkers using transcriptomic data in non-small-cell lung cancer

B Győrffy, P Surowiak, J Budczies, A Lánczky - PloS one, 2013 - journals.plos.org
In the last decade, optimized treatment for non-small cell lung cancer had lead to improved
prognosis, but the overall survival is still very short. To further understand the molecular …

[HTML][HTML] Pancancer survival analysis of cancer hallmark genes

Á Nagy, G Munkácsy, B Győrffy - Scientific reports, 2021 - nature.com
Cancer hallmark genes are responsible for the most essential phenotypic characteristics of
malignant transformation and progression. In this study, our aim was to estimate the …

[HTML][HTML] Survival analysis across the entire transcriptome identifies biomarkers with the highest prognostic power in breast cancer

B Győrffy - Computational and structural biotechnology journal, 2021 - Elsevier
Introduction Extensive research is directed to uncover new biomarkers capable to stratify
breast cancer patients into clinically relevant cohorts. However, the overall performance …

[HTML][HTML] Cutoff Finder: a comprehensive and straightforward Web application enabling rapid biomarker cutoff optimization

J Budczies, F Klauschen, BV Sinn, B Győrffy… - PloS one, 2012 - journals.plos.org
Gene or protein expression data are usually represented by metric or at least ordinal
variables. In order to translate a continuous variable into a clinical decision, it is necessary to …

[HTML][HTML] Cross-validation of survival associated biomarkers in gastric cancer using transcriptomic data of 1,065 patients

AM Szász, A Lánczky, Á Nagy, S Förster, K Hark… - Oncotarget, 2016 - ncbi.nlm.nih.gov
Results The entire database incorporates 1,065 gastric carcinoma samples, gene
expression data. Out of 29 established markers, higher expression of BECN1 (HR= 0.68, p …

Implementing an online tool for genome-wide validation of survival-associated biomarkers in ovarian-cancer using microarray data from 1287 patients.

B Győrffy, A Lánczky, Z Szállási - Endocrine-related cancer, 2012 - real.mtak.hu
The validation of prognostic biomarkers in large independent patient cohorts is a major
bottleneck in ovarian cancer research. We implemented an online tool to assess the …